Rofo 2002; 174(7): 809-818
DOI: 10.1055/s-2002-32688
Übersicht
© Georg Thieme Verlag Stuttgart · New York

Beckenarterienembolisationen bei
gynäkologischen Blutungen

Pelvic artery embolization in gynecological bleedingK.  A.  Hausegger, H.  Schreyer, H.  Bodhal
  • 1Universitätsklinik für Radiologie Graz, Austria
Further Information

Publication History

Publication Date:
08 July 2002 (online)

Zusammenfassung

Gynäkologische Blutungen können schwangerschaftsbedingt sein, oder durch Myome oder maligne Tumore hervorgerufen werden. In allen Fällen ist die Transkatheterembolisation ein effektives therapeutisches Verfahren. Die angewandte Embolisationstechnik hängt von der Ätiologie der Blutung ab. Bei schwangerschaftsbedingten Blutungen ist ein temporärer Embolisationseffekt erwünscht, die Embolisation erfolgt daher mit Spongostan. Bei Myomen und Malignomen wird ein permanenter Embolisationseffekt durch die Verwendung von PVA-Partikeln angestrebt. Der technische und klinische Erfolg der Embolisation liegt unabhängig von der Ätiologie der Blutungen über 90 %. In der Regel wird bei Embolisationen von Myomen und Malignomen ein Postembolisationssyndrom mit Schmerzen und Fieber beobachtet. Diese Symptome bilden sich jedoch meist innerhalb von 2 - 3 Tagen zurück. Bei sorgfältiger Beachtung der angiographischen Technik sowie der Technik der Einschwemmembolisation sind Komplikationen durch ischämische Schädigung gesunder Organstrukturen selten. Bei gynäkologischen Blutungen sollte die Transkatheterembolisation als therapeutische Option stets in Betracht gezogen werden.

Abstract

The most common reasons for gynecological bleeding are pregnancy-related disorders, fibroids of the uterus, and gynecological malignances. Transarterial embolization is an effective treatment modality for gynecological bleeding regardless of its etiology. Depending on the underlying disease, a different technique of embolization is applied. In postpartal bleeding a temporary effect of embolization is desired, therefore gelatine sponge is used as embolizing agent. In fibroids and malignant tumors the effect should permanent, therefore PVA particles are used. Regardless the etiology, the technical and clinical success of transarterial embolization is at least 90 %. In nearly every patient a post-embolization syndrome can be observed, represented by local pain and fever. This post-embolization syndrome usually does not last longer than 3 days. If embolization is performed with meticulous attention to angiographic technique and handling of embolic material, ischemic damage of adjacent organs is rarely observed. Transarterial embolization should be an integrative modality in the treatment of gynecological bleeding.

Literatur

  • 1 Wallach E E. Myomectomy. In: Thompson JD, Rock JA, eds The Linde's operative gynecology. Philadelphia Pa: Lippincott 1992 7: 647-662
  • 2 Gilbert W M, Moore T R, Resnik R, Doemeny J, Chin H, Bookstein J J. Angiographic embolization in the management of hemorrhagic complications of pregnancy.  Am J Obstet Gynecol. 1992;  166 493-497
  • 3 Lang E K. Transcatheter embolization of pelvic vessels for control of intractable hemorrhage.  Radiology. 1981;  140 331-339
  • 4 Lahousen M, Schreyer H. Transcatheter embolization of pelvic arteries for control of intractable tumor bleeding. In: E. Burghardt Hrsg Surgical Gynecologic Oncology. Thieme, Stuttgart 1993: 670-674
  • 5 Pelage J P, Le D ref, Mateo J, Soyer P, Jacob D, Kardache M, Dahan H, Repiquet D, Payen D, Truc J B, Maerland J J, Rymer R. Life-threatening primary postpartum hemorrhage: treatment with emergency selective arterial embolization.  Radiology. 1998;  208 359-362
  • 6 Spies J B, Ascher S A, Roth A R, Kim J, Levy E B, Gomez-Jorge J. Uterine artery embolization for leiomyomata.  Obstetrics and Gynecology. 2001;  98 29-34
  • 7 Vedantham S, Goodwin S C, McLucas B, Mohr G. Uterine artery embolization: an underused method of controlling pelvic hemorrhage.  Am J Obstet Gynecol. 1997;  176 938-948
  • 8 Kadir S. Abdominal Aorta and Pelvis.  In: Normal and variant angiographic anatomy; S Kadir. Hrsg W.B. Saunders Company 1991
  • 9 Burchell R C. Physiology of internal iliac artery ligation.  J Obstet Gynaec Brit Cwlth. 1968;  75 642-651
  • 10 Chait A, Moltz A, Nelson J H. The collateral arterial circulation in the pelvis.  Am J Roengenol. 1968;  102 392-400
  • 11 Evans S, McShane P. The efficacy of internal iliac artery ligation in obstetric hemorrhage.  Surg Gynecol Obstet. 1985;  160 250-253
  • 12 Greenwood L H, Glickman M G, Schwartz P E, Morse S S, Denny D F. Obstetric and nonmalignant gynecologic bleeding: treatment with angiographic embolization.  Radiology. 1987;  164 155-159
  • 13 Jander H P, Russinovich N AE. Transcatheter gelfoam embolization in abdominal, retroperitoneal, and pelvic hemorrhage.  Radiology. 1980;  136 337-344
  • 14 Pisco J M, Martins J M, Correia M G. Internal iliac artery embolization to control hemorrhage from pelvic neoplasm.  Radiology. 1989;  172 337-342
  • 15 Hendrickx P, Orth G, Grumerth J H. Long-term survival after embolization of potentially lethal bleeding malignant pelvic tumors.  Br J Radiol. 1995;  68 1336-1340
  • 16 Derdeyn C P, Moran C J, Cross D T, Dietrich H H, Dacey R G jr. Polyvinyl alcohol particle size and suspension characteristics.  AJNR Am J Neuroradiol. 1995;  16 1335-1343
  • 17 Coldwell D M, Stokes K R, Yakes W F. Embolotherapy: agents, clinical applications, and techniques.  RadioGraphics. 1994;  14 623-643
  • 18 Rosenthal D M, Colapinto R. Angiographic arterial embolization and management of postoperative vaginal hemorrhage.  Am J Obstet Gynecol. 1985;  75 642-651
  • 19 Stancato-Pasic A, Mitty H A, Richard III H M, Eshkar N. Obstetric embolotherapy: effect on menses and pregnancy.  Radiology. 1997;  204 791-793
  • 20 O'Leary J A. Uterine artery ligation in the control of postcesarean hemorrhage.  J Reprod Med. 1995;  40 189-193
  • 21 Broder M S, Kanouse D E, Mittman B S, Bernstein S J. The appropriatness of recommendations for hysterectomy.  Obstet Gynecol. 2000;  95 199-205
  • 22 Phillips D R, Milim S J, Nathanson H G, Haselkorn J S. Experience with laparoscopic leiomyoma coagulation and concomitant operative hysteroscopy.  J Am Assoc Gynecol Laparosc. 1997;  4 425-433
  • 23 Hutchins F L, Worthington-Kirsch R, Berkowitz R P. Selective uterine artery embolization due to adenomyosis.  J Vasc Interv Radiol. 1999;  10 1171-1174
  • 24 Ravina J H, Herbreteau D, Ciraru-Vigneron N, Bouret J M, Houdart E, Aymard A, Merland J J. Arterial embolisation to treat uterine myomata.  Lancet. 1995;  346 671-672
  • 25 Goodwin S C, McLucas B, Lee M, Chen G, Perrella R, Vedantham S, Muir S, Lai A, Sayre J W, DeLeon M. Uterine artery embolization for the treatment of uterine leiomyomata midterm results.  J Vasc Interv Radiol. 1999;  10 1159-1165
  • 26 Siskin G P, Stainken B F, Dowling K, Meo P, Ahn J, Dolen E G. Outpatient uterine artery embolization for symptomatic uterine fibroids: experience in 49 patients.  J Vasc Interv Radiol. 2000;  11 305-331
  • 27 Siskin G P, Eaton L A, Stainken B F, Dowling K, Herr A, Schwartz J. Pathologic findings in a uterine leiomyoma after bilateral uterine artery embolization.  J Vasc Interv Radiol. 1999;  10 891-894
  • 28 Persaud V, Arjoon P D. Uterine leiomyoma: incidence of degenerative change and a correlation of associated symptoms.  Obstet Gynecol. 1970;  35 432-436
  • 29 Smith S J, Sewall L E, Handelsman A. A clinical failure of uterine fibroid embolization due to adenomyosis.  J Vasc Interv Radiol. 1999;  10 1171-1174
  • 30 Tsuda H, Kawabata M, Nakamoto O, Yamamoto K. Clinical predictors in the natural history of uterine leiomyoma: preliminary study.  J Ultrasound Med. 1998;  17 17-20
  • 31 Farrer-Brown G, Beilby J OW, Tarbit M H. The vascular patterns in myomatous uteri.  J Obstet Gynaecol Br Commonwealth. 1970;  77 967-975
  • 32 Spies J B, Scialli A R, Jha R C, Imaoka I, Ascher S M, Fraga V M, Barth K H. Initial results from uterine fibroid embolization for symptomatic leiomyomata.  J Vasc Interv Radiol. 1999;  10 1149-1157
  • 33 Nikolic B, Spies J B, Abbara S, Goodwin S C. Ovarian artery supply of uterine fibroids as a cause of treatment failure after uterine artery embolization: a case report.  J Vasc Interv Radiol. 1999;  10 1167-1170
  • 34 Pelage J, DeDref O, Soyer P, Kardache M, Dahan H, Abitol M. et al . Fibroid-related menorrhagia: Treatment with superselective embolization of the uterine arteries and midterm follow-up.  Radiology. 2000;  215 428-431
  • 35 Ravina J, Bouret J, Cirary-Vigneron N, Repiquet D, Herbreteau D, Aymard A. et al . Application of particulate arterial embolization in the treatment of uterine fibromyomata.  Bull Acad Natl Med. 1997;  181 233-243
  • 36 Worthington-Kirsch R L, Popky G L, Hutchins F L jr. Uterine arterial embolization for the management of leiomyomas: quality-of-life assessment and clinical response.  Radiology. 1998;  208 625-629
  • 37 Bradley E A, Reidy J F, Forman R G, Jarosz J, Braude P R. Transcatheter uterine artery embolisation to treat large uterine fibroids.  Br J Obstet Gynaecol. 1998;  105 235-240
  • 38 Poppe W, van Assche F A, Wilms G, Favril A, Baert A. Pregnancy after transcatheter embolization of a uterine arteriovenous malformation.  Am J Obstet Gynecol. 1987;  156 1179-1180
  • 39 Smith S J. Uterine fibroid embolization.  Am Family Physician. 2000;  61 3601-3607, 3611-3612
  • 40 Vashisht A, Studd J, Carey A, Burn P. Fatal septicaemia after fibroid embolisation.  The Lancet. 1999;  354 307-308
  • 41 Stone H H, Hopper C A, Kolb D L, Geheber C E, Dawkins E J. Antibiotic prophylaxis in gastric, biliary and colonic surgery.  Ann Surg. 1976;  184 443-452
  • 42 Goldstein H M, Medelin H, Ben-Menachem Y, Wallace S. Transcatheter arterial embolization in the management of bleeding in the cancer patient.  Radiology. 1975;  115 603-608
  • 43 Miller F J, Mortel R, Mann W J. Selective arterial embolization for control of hemorrhage in pelvic malignancy: femoral and brachial catheter approaches.  Am J Roentgenol. 1976;  126 1028-1032
  • 44 Dehack C MC. Transcatheter embolization of pelvic vessels to stop intractable hemorrhage.  Gynecol Oncol. 1986;  24 9-16
  • 45 Majewski A, Luska G, Mlasowsky B, Lelle R, Wagner H H. Ergebnisse der perkutanen transkatheterealen Embolotherapie bei schweren Blutungen im Becken.  Fortschr Röntgenstr. 1987;  147 591-598
  • 46 van Allen R J, Pentecost M J. Transcatheter control of hemorrhage in the cancer patients.  Semin Intervent Radiol. 1992;  9 38-43
  • 47 Carmignani G, Belgrano E, Poppo P. Transcatheter embolization of hypogastric arteries in cases of bladder hemorrhage from advanced pelvic cancers: follow up in 9 cases.  J Urol. 1980;  124 196-200
  • 48 Yamashita Y, Harada M, Yamamoto H, Miyazaki T, Takahashi M, Miyazaki K, Okamura H. Transcatheter arterial embolization of obstetric and gynaecological bleeding: efficacy and clinical outcome.  Brit J Radiol. 1994;  67 530-534
  • 49 Hare W SC, Holland C J. Paresis following internal iliac artery embolization.  Radiology. 1983;  146 47-51
  • 50 Braf Z F, Koontz W W. Gangrene of bladder, complication of hypogastric artery embolization.  Urology. 1977;  9 670-671
  • 51 Hietala S O. Urinary bladder necrosis following selective embolization of the internal iliac artery.  Acta Radiol Diagn. 1978;  19 316-320

ao. Univ. Prof. Dr. Klaus A. Hausegger

Universitätsklinik für Radiologie, Karl-Franzens-Universität Graz


Auenbrugger Platz 9

8036 Graz

Österreich

Phone: 0043-316-385-2220

Fax: 0043-316-385-3851

Email: klaus.hausegger@kfunigraz.ac.at